Collagen Solutions Announces Completion of Assessments in ChondroMimetic Study

Collagen Solutions completed the final patient assessment in the eight-year extension clinical study of 15 patients who received a ChondroMimetic implant for the repair of cartilage defects in the knee.

With the last patient enrolled, data is being compiled and audited for submission as part of a package for regulatory approval and re-establishment of the CE mark, with ex-U.S. commercialization expected in mid-2018.

Collagen Solutions is a global supplier, developer and manufacturer of medical grade collagen, tissues and related medical devices and components for use in regenerative medicine, medical devices and in vitro diagnostics and research.

Source: Collagen Solutions

Save Supplier